7,886 Shares in Dolby Laboratories $DLB Acquired by MQS Management LLC

MQS Management LLC bought a new position in Dolby Laboratories (NYSE:DLB) during the second quarter, Holdings Channel.com reports. The fund bought 7,886 shares of the electronics maker’s stock, valued at approximately $586,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Focus Partners Advisor Solutions LLC raised its holdings in shares of Dolby Laboratories by 27.8% in the 2nd quarter. Focus Partners Advisor Solutions LLC now owns 4,312 shares of the electronics maker’s stock worth $320,000 after purchasing an additional 939 shares in the last quarter. State of New Jersey Common Pension Fund D increased its position in shares of Dolby Laboratories by 4.9% in the second quarter. State of New Jersey Common Pension Fund D now owns 24,923 shares of the electronics maker’s stock worth $1,851,000 after acquiring an additional 1,158 shares in the last quarter. Asset Management One Co. Ltd. purchased a new position in shares of Dolby Laboratories in the second quarter worth approximately $571,000. Bayforest Capital Ltd purchased a new position in shares of Dolby Laboratories in the second quarter worth approximately $147,000. Finally, Equitable Trust Co. increased its position in shares of Dolby Laboratories by 3.3% in the second quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock worth $413,000 after acquiring an additional 177 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.

Dolby Laboratories Stock Performance

Shares of DLB opened at $67.38 on Friday. The company’s 50 day moving average price is $71.40 and its 200 day moving average price is $73.53. Dolby Laboratories has a 52 week low of $66.96 and a 52 week high of $89.66. The company has a market capitalization of $6.46 billion, a PE ratio of 24.68 and a beta of 0.92.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating analysts’ consensus estimates of $0.72 by $0.06. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. During the same period in the previous year, the firm posted $0.71 earnings per share. The firm’s revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, equities analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories’s payout ratio is currently 48.35%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Dolby Laboratories in a research report on Friday. Barrington Research reissued an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, September 12th. Rosenblatt Securities reissued a “buy” rating and issued a $95.00 target price on shares of Dolby Laboratories in a research report on Friday, August 1st. Finally, Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $95.75.

Insider Activity at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total value of $1,721,750.00. Following the completion of the sale, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at $7,901,110.75. The trade was a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the business’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares of the company’s stock, valued at $5,276,990.20. This represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 82,000 shares of company stock valued at $5,845,440 over the last three months. Insiders own 38.39% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.